Compare ImmunityBio Inc. Common Stock (IBRX) vs Onto Innovation (ONTO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Onto Innovation — how do they compare? ImmunityBio Inc. Common Stock trades at $10.6 (market cap $10.51B), while Onto Innovation trades at $294.89 (market cap $14.36B). The key difference: Onto Innovation is the larger of the two by market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, Onto Innovation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Onto Innovation for 5 Days on average.
| IBRX | ONTO | |
|---|---|---|
Market Cap | $10.51B | $14.36B |
Volume | 10,445,785 | 761,617 |
Sector | Health | Technology |
52-Week High | $11.55 | $378.45 |
52-Week Low | $1.98 | $121.34 |
Typical Hold Time | 0 Days | 5 Days |
Enterprise Value | $10.97B | $13.95B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Onto Innovation
Onto Innovation provides process control solutions for semiconductor manufacturing. Its inspection and metrology systems help chipmakers measure, analyze, and detect defects on wafers and advanced packages.
Read more on ONTO →
